In this webinar, Chairs and Co-chairs of the Member State Coordination Group on Health Technology Assessment (HTACG) and its subgroups explained the process for joint clinical assessments and joint scientific consultations. The webinar also covered...
The European Medicines Agency (EMA) is hosting a workshop on supporting innovation in cardiovascular medicines and medical devices in the EU. This multi-stakeholder workshop will cover interdisciplinary discussions addressing a range of important topics including...
The European Medicines Agency (EMA) is hosting a workshop on supporting innovation in cardiovascular medicines and medical devices in the EU. This multi-stakeholder workshop will cover interdisciplinary discussions addressing a range of important topics including...
The 6th EMA-AESGP bilateral meeting is organised in the context of the EMA annual bilateral meetings with industry stakeholder organisations. The purpose of the meeting is to exchange views and promote dialogue on topics of...
The seventh EMA-EUROPABIO bilateral meeting is organised in the context of the EMA annual bilateral meetings with industry stakeholder organisations. The purpose of the meeting is to exchange views and promote dialogue on topics of...
This meeting between European Medicines Agency (EMA) and Medicines for Europe is organised in the context of the EMA annual bilateral meetings with industry stakeholder organisations. The purpose of the meeting is to exchange views...
This joint hybrid HMA/EMA workshop on Patient Registries follows on the successful disease-specific workshops held between 2017 and 2019, as well as the EMA multi-stakeholder workshop on qualification of Patient Registries held in 2024. The...
The Industry Standing Group (ISG) is a forum for interaction that has been established as part of the EMA’s continuous improvement for engagement with industry stakeholders supply chain of human, veterinary and medical device sectors...
The 15th industry stakeholder platform on the operation of the centralised procedure for human medicines continues the series of regular exchanges between regulators and representatives of industry stakeholder organisations, aiming to foster constructive dialogue on...
The Industry Standing Group (ISG) is a forum for interaction that has been established as part of the EMA’s continuous improvement for engagement with industry stakeholders supply chain of human, veterinary and medical device sectors...
